1. Signaling Pathways
  2. Cell Cycle/DNA Damage
  3. PPAR
  4. PPAR Inhibitors

PPAR Inhibitors

PPARα

PPARβ/δ

PPARγ

PPAR

PPARδ

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

PPAR Inhibitors, Agonists, Antagonists, Activators & Modulators
Product Name PPARα PPARβ/δ PPARγ PPAR PPARδ Purity
Retinoic acid
PPARα, Kd: 103 nM
PPARβ/δ, Kd: 17 nM
PPARγ, Kd: 178 nM
    99.74%
Rosiglitazone    
PPARγ, Kd: 40 nM
PPARγ, EC50: 60 nM
    99.90%
GW9662
PPARα, IC50: 32 nM
PPARδ, IC50: 2000 nM
PPARγ, IC50: 3.3 nM
    99.87%
Pioglitazone
hPPARα, EC50: 100 μM
mouse PPARα, EC50: 100 μM
hPPARδ, EC50: 43 μM
hPPARγ, EC50: 0.93 μM
mouse PPARγ, EC50: 0.99 μM
    99.66%
Leriglitazone hydrochloride    
PPAR-γ
    99.58%
Rosiglitazone potassium    
PPARγ, Kd: 40 nM
PPARγ, EC50: 60 nM
   
Fenofibrate
PPARα, IC50: 30 μM
        99.92%
GW6471
PPARα
        98.81%
T0070907
PPARα, Ki: 0.85 μM
PPARδ, Ki: 1.8 μM
PPARγ, Ki: 1 nM
    99.98%
Pirinixic acid
PPARα, EC50: 0.63 μM
 
PPARγ, EC50: 32 μM
    99.80%
Troglitazone    
PPARγ, EC50: 550 nM (Human PPARγ)
    98.60%
5-Aminosalicylic Acid    
PPARγ
    ≥98.0%
GW 501516  
PPARδ, EC50: 1.1 nM
      99.15%
Astaxanthin    
PPARγ
    ≥98.0%
Icariin
PPARα
        99.06%
Lanifibranor
PPARα, EC50: 1537 nM (Human PPARα)
PPARδ, EC50: 866 nM (Human PPARδ)
PPARγ, EC50: 206 nM (Human PPARγ)
    99.56%
Elafibranor
PPAR-α, EC50: 45 nM
PPAR-δ, EC50: 175 nM
      99.00%
Daidzein
PPAR-α
 
PPAR-γ
    99.89%
GW0742
PPARα, EC50: 1.1 μM
PPARδ, EC50: 1 nM
PPARγ, EC50: 2 μM
    99.95%
Bezafibrate
hPPARα, EC50: 50 μM
hPPARδ, EC50: 20 μM
hPPARγ, EC50: 60 μM
    99.43%
FH535      
PPAR
  99.87%
GW7647
PPARα, EC50: 6 nM (Human PPARα)
PPARδ, EC50: 6.2 μM (Human PPARδ)
PPARγ, EC50: 1.1 μM (Human PPARγ)
    98.22%
GW1929    
PPAR-γ, pEC50: 8.56 (Human PPAR-γ)
    99.87%
GSK3787  
PPARδ, pIC50: 6.6 nM
      99.04%
CDDO-Im
PPARα, Ki: 232 nM
 
PPARγ, Ki: 344 nM
    98.19%
Candesartan    
PPAR-γ
    98.50%
Rosiglitazone maleate    
PPARγ1, EC50: 30 nM
PPARγ2, EC50: 100 nM
    99.75%
Glabridin    
PPARγ, EC50: 6.1 μM
    99.98%
Eupatilin
PPARα
        98.49%
Pioglitazone hydrochloride
PPARα, EC50: 0.93 μM (Human PPARα)
PPARδ, EC50: 0.01 μM (Human PPARδ)
PPARγ, EC50: 43 μM (Human PPARγ)
    99.75%
Palmitelaidic Acid
PPARα
        ≥99.0%
Gemfibrozil
PPAR-α
        99.91%
Seladelpar sodium salt  
PPAR-δ, EC50: 2 nM
      98.39%
Clofibrate
PPARα, EC50: 50 μM
 
PPARγ, EC50: 500 μM
    99.61%
Magnolol    
PPARγ, EC50: 17.7 μM
    99.92%
Saroglitazar
PPARα, EC50: 0.65 pM (HepG2 cell)
 
PPARγ, EC50: 3 nM (HepG2 cell)
    98.07%
AZD-9574      
PPAR
  99.11%
Oleoylethanolamide
PPAR-α
        99.55%
Fenofibric acid
PPARα, EC50: 22.4 μM
PPARδ, EC50: 1.06 μM
PPARγ, EC50: 1.47 μM
    99.94%
Alpinetin    
PPAR-γ
    99.89%
Oleuropein    
PPARγ
    99.05%
NXT629
hPPARα, IC50: 77 nM
hPPARδ, IC50: 6 μM
hPPARγ, IC50: 15 μM
    99.20%
L-165041  
PPARδ, Ki: 6 nM
PPARγ, Ki: 730 nM
    99.74%
Avicularin    
PPARγ
    99.48%
Saroglitazar magnesium
PPARα, EC50: 0.65 pM (HepG2 cell)
 
PPARγ, EC50: 3 nM (HepG2 cell)
    98.85%
DG172 dihydrochloride  
PPARβ/δ, IC50: 27 nM
      99.03%
Mifobate    
PPARγ, IC50: 140 μM
    99.77%
Indeglitazar
PPARα
PPARδ
PPARγ
    99.59%
Raspberry ketone
PPAR-α
        99.93%
Ginsenoside Rh1    
PPAR-γ
    ≥98.0%
Balaglitazone    
PPARγ, EC50: 351 nM (Human PPARγ)
    99.97%
15-Deoxy-Δ-12,14-prostaglandin J2    
PPARγ, EC50: 2 μM
   
EHP-101    
PPARγ
    98.56%
Oroxin A    
PPARγ
    99.80%
Ophiopogonin D
PPARα
        98.59%
Agrimol B    
PPARγ
    99.75%
Inolitazone dihydrochloride    
PPARγ
    98.36%
BMS-687453
PPARα, IC50: 260 nM (Human PPARα)
        98.58%
Gypenoside XLIX
PPAR-α
        99.35%
Cefminox sodium    
PPARγ
    99.83%
SR1664    
PPAR-γ, IC50: 80 nM
    ≥98.0%
Ciprofibrate
PPARα
        99.79%
Aleglitazar
PPARα, IC50: 38 nM
 
PPARγ, IC50: 19 nM
    99.30%
Adelmidrol    
PPARγ
    ≥98.0%
MA-0204  
PPARδ, EC50: 0.4 nM (in human)
PPARδ, EC50: 7.9 nM (in mouse)
PPARδ, EC50: 10 nM (in rat)
      99.31%
Chiglitazar
PPARα, EC50: 1.8 μM
PPARδ, EC50: 1.7 μM
PPARγ, EC50: 0.08 μM
   
Licarin B    
PPARγ
    99.71%
Fmoc-leucine    
PPARγ
    99.58%
Bilobetin
PPARα
        98.30%
FK614    
PPAR-γ
    99.82%
AMG131    
PPARγ
    99.13%
Methyl oleanonate    
PPARγ
    99.49%
Falcarindiol    
PPARγ
    99.48%
4-O-Methyl honokiol    
PPARγ
    99.65%
HWL-088  
PPARδ, EC50: 570.9 nM
      98.80%
Seladelpar
PPAR-α, EC50: 1600 nM
PPAR-δ, EC50: 2 nM
     
Angeloylgomisin H    
PPAR-γ
    99.40%
CP-868388 free base
hPPARα, Ki: 10.8 nM
 
hPPARγ, Ki: 3.47 μM
    99.84%
GSK376501A    
PPARγ
    99.06%
CUDA
PPARα
        ≥98.0%
PPAR agonist 1
PPARα
 
PPARγ
   
Rosiglitazone hydrochloride    
PPARγ, EC50: 60 nM
PPARγ, Kd: 40 nM
   
Pioglitazone potassium
hPPARα, EC50: 100 μM
mouse PPARα, EC50: 100 μM
hPPARδ, EC50: 43 μM
mouse PPARγ, EC50: 0.99 μM
h-PPARγ, EC50: 0.93 μM
   
Pparδ agonist 5        
PPARδ, EC50: 0.335 μM
MSDC-0602K    
PPAR-γ, IC50: 18.25 μM
   
Glabrone    
PPAR-γ
    99.08%
Ciprofibrate impurity A
PPARα
       
LJ570
PPARα, EC50: 1.05 μM
 
PPARγ, EC50: 0.12 μM
   
Caulophyllogenin    
PPARγ, EC50: 12.6 μM
   
Pparδ agonist 1  
PPARδ, EC50: 5.06 nM
     
Netoglitazone
PPARα
 
PPARγ
   
Darglitazone Sodium    
PPAR-γ
   
Darglitazone    
PPAR-γ
   
PPARγ/δ modulator 1    
PPARγ, Ki: 5.31 μM
 
PPARδ, Ki: 14.4 nM
BAY-0069    
hPPARγ, IC50: 6.3 nM
mouse PPARγ, IC50: 24 nM
   
10-Nitrolinoleic acid    
PPARγ, IC50: 0.22 μM
   
GW1929 hydrochloride    
hPPARγ, pKi: 8.84
   
Fonadelpar  
PPARδ
     
Edaglitazone
PPARα, EC50: 1053 nM
 
PPARγ, EC50: 35.6 nM
   
PPARα/γ agonist 1
PPARα, EC50: 28 nM
 
PPARγ, EC50: 69 nM
   
LT175
hPPARα, EC50: 0.22 μM
mPPARα, EC50: 0.26 μM
 
hPPARγ, EC50: 0.48 μM
   
PPARγ-IN-1    
PPARγ
   
Pparδ agonist 2  
PPARδ
     
H-​Trp-​Glu-​OH    
PPARγ, Kd: 8 μM
   
GSK1820795A    
hPPARγ, EC50: 0.25 μM
mouse PPARγ, EC50: 0.27 μM
   
KD-3010  
PPARδ
     
DS-6930    
PPARγ, EC50: 41 nM
   
Ertiprotafib
PPARα, EC50: ~1 μM
PPARβ, EC50: ~1 μM
      98.86%
BAY-4931    
PPAR-γ, IC50: 0.17 nM (RT112-FABP4-NLucP cellular reporter assay)
mouse PPARγ, IC50: 0.14 nM (GAL4-NHR-LBD one hybrid reporter assay )
hPPARγ, IC50: 0.40 nM (GAL4-NHR-LBD one hybrid reporter assay )
   
PPARα/δ agonist 1
PPARα, EC50: 7 nM
 
PPARγ, EC50: 1316.1 nM
 
PPARδ, EC50: 8.4 nM
SR2595    
PPARγ, IC50: 30 nM
   
SR 16832    
PPARγ
   
13-Oxo-9E,11E-octadecadienoic acid
PPARα
       
PPARγ agonist 2    
PPARγ
   
Mesalamine impurity P      
PPAR
 
ST247  
PPARβ/δ
     
GW 9578
mouse PPARα, EC50: 5 nM
h-PPARα, EC50: 50 nM
       
Norathyriol
PPARα, IC50: 92.8 μM
PPARβ, IC50: 102.4 μM
PPARγ, IC50: 153.5 μM
   
PPARγ phosphorylation inhibitor 1    
PPARγ, IC50: 24 nM
   
PPARα agonist 1
hPPARα
       
Imiglitazar
PPARα, EC50: 67 nM
 
PPARγ1, EC50: 31 nM
   
Inolitazone    
PPARγ
   
AVE-8134
PPARα, EC50: 100 nM (Human PPARα)
       
Arhalofenate    
PPAR-γ
   
PPARα-MO-1
PPARα